Melissa Baird - Dec 27, 2024 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role: Chief Operating Officer
Signature: /s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Stock symbol: HIMS
Transactions as of: Dec 27, 2024
Transactions value $: $143,669
Form type: 4
Date filed: 12/30/2024, 04:22 PM
Previous filing: Dec 17, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HIMS	Class A Common Stock	Options Exercise	$130K	+26K	+3.85%	$5.01	701K	Dec 27, 2024	Direct
transaction	HIMS	Class A Common Stock	Options Exercise	$13.4K	+5.52K	+0.79%	$2.43	707K	Dec 27, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HIMS	Stock Option (right to buy)	Options Exercise	$0	-26K	-1.57%	$0.00	1.64M	Dec 27, 2024	Class A Common Stock	26K	$5.01	Direct	F1
transaction	HIMS	Stock Option (right to buy)	Options Exercise	$0	-5.52K	-0.74%	$0.00	738K	Dec 27, 2024	Class A Common Stock	5.52K	$2.43	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting on March 24, 2022 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.
F2	Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.

Content

The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting on March 24, 2022 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.

Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.